Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Research and Practice in Thrombosis and Haemostasis|December 1, 2021
Adherence to rivaroxaban for the treatment of venous thromboembolism-Results from the FIRST registryVictoria Speed, Vivian Auyeung, Jignesh P Patel, et al.
BMC Pregnancy and Childbirth|November 20, 2014
Changes in thrombin generation and D-dimer concentrations in women injecting enoxaparin during pregnancy and the puerperiumJignesh P Patel, Raj K Patel, Lara N Roberts, et al.
Thrombosis Research|March 12, 2014
Women with unexplained recurrent pregnancy loss do not have evidence of an underlying prothrombotic state: experience with calibrated automated thrombography and rotational thromboelastometrySarah A Bennett, Catherine N Bagot, Adjoa Appiah, et al.
Drug Testing and Analysis|August 2, 2012
Monitoring of florfenicol residues in fish muscle by HPLC-UV with confirmation of suspect results by LC-MS/MSRodrigo H M M Granja, Andreia C de Lima, Raj K Patel, et al.
Thrombosis Research|November 21, 2021
Long-term adherence to direct acting oral anticoagulants and the influence of health beliefs after switching from vitamin-K antagonists: Findings from the Switching StudyJohn K Bartoli-Abdou, Jignesh P Patel, Bipin Vadher, et al.
BMC Hematology|August 26, 2016
Anticoagulated patient's perception of their illness, their beliefs about the anticoagulant therapy prescribed and the relationship with adherence: impact of novel oral anticoagulant therapy - study protocol for The Switching Study: a prospective cohort studyVivian Auyeung, Jignesh P Patel, John K Abdou, et al.
Blood|August 4, 2020
Postdischarge venous thromboembolism following hospital admission with COVID-19Lara N Roberts, Martin B Whyte, Loizos Georgiou, et al.
Thrombosis Research|January 7, 2018
Exploration of adherence and patient experiences with DOACs one year after switching from vitamin-K antagonists- insights from the switching studyJohn K Bartoli-Abdou, Jignesh P Patel, Jacob Crawshaw, et al.
Research and Practice in Thrombosis and Haemostasis|July 27, 2018
Associations between illness beliefs, medication beliefs, anticoagulation-related quality of life, and INR control: Insights from the Switching StudyJohn K Bartoli-Abdou, Jignesh P Patel, Rosa Xie, et al.
Thrombosis Research|August 24, 2024
Can edoxaban be used at extremes of bodyweight and in patients with a creatinine clearance ≥95 ml/min? - A population pharmacokinetic analysisRachel E Clapham, Victoria Speed, Rosalind Byrne, et al.
Pageof 4